|
ZNF74 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.168170E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.963800E-03 |
| Normal-vs-Stage2 |
5.833000E-01 |
| Normal-vs-Stage3 |
1.479860E-03 |
| Normal-vs-Stage4 |
9.767500E-04 |
| Stage1-vs-Stage2 |
3.444300E-02 |
| Stage1-vs-Stage3 |
2.375800E-01 |
| Stage1-vs-Stage4 |
1.655980E-01 |
| Stage2-vs-Stage3 |
1.145530E-02 |
| Stage2-vs-Stage4 |
6.738400E-03 |
| Stage3-vs-Stage4 |
6.531400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.337800E-03 |
| Normal-vs-AfricanAmerican |
2.310200E-02 |
| Normal-vs-Asian |
3.746400E-02 |
| Caucasian-vs-AfricanAmerican |
4.838800E-01 |
| Caucasian-vs-Asian |
8.695400E-01 |
| AfricanAmerican-vs-Asian |
4.183800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.037800E-02 |
| Normal-vs-Female |
1.201590E-02 |
| Male-vs-Female |
7.716600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.124300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.035570E-02 |
| Normal-vs-Age(61-80Yrs) |
1.968020E-01 |
| Normal-vs-Age(81-100Yrs) |
7.236800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.971400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.344400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.109400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.448200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.030800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.059400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.9000999999983E-05 |
| Classical-VS-Follicular |
5.928800E-01 |
| Classical-VS-Other |
8.736800E-01 |
| Classical-VS-Normal |
1.568210E-02 |
| Tall-VS-Follicular |
1.955380E-03 |
| Tall-VS-Other |
3.495000E-01 |
| Tall-VS-Normal |
1.27110000003317E-06 |
| Follicular-VS-Other |
7.926200E-01 |
| Follicular-VS-Normal |
2.179200E-01 |
| Other-VS-Normal |
3.041000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.262780E-01 |
| Normal-vs-N1 |
2.196000E-04 |
| N0-vs-N1 |
3.599500E-03 |
|
|
